For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Good relations: Supporting doctors and pharmacists to work together
Good relations: Supporting doctors and pharmacists to work together

New work by researchers from Victoria University of Wellington sheds light on how pharmacists and doctors work together to advance patients’ access to, and use of, pharmaceuticals
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. McGuigan, K. Producing community pharmacy: Complex performances in a hybrid space [PhD thesis]. Auckland, NZ: Massey University; 2018.
2. Broom A, Broom J, Kirby E, et al. The path of least resistance? Jurisdictions, responsibility and professional asymmetries in pharmacists’ accounts of antibiotic decisions in hospitals. Soc Sci Med 2015;146:95–103.
3. Addison C, Taylor D. The pharmacist as safety net: an interview-based study of the intersecting dependencies between doctors and pharmacists. J Pharm Policy Pract 2023;16(1):40.
4. Bidwell S, Thompson L. GPs, community pharmacists and shifting professional boundaries. N Z Med J 2015;128(1414):19–26.
5. Bollen A, Harrison R, Aslani P, et al. Factors influencing interprofessional collaboration between community pharmacists and general practitioners-A systematic review. Health Soc Care Community 2019;27(4):e189–212.